LT

Lakshmi Tilak Solingapuram

Active Director Director DIN 11365581
DIN 11365581 First appointment Nov 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmi Tilak Solingapuram

Data last updated:

Lakshmi Tilak Solingapuram is a Director at Udayhelios Hospitals Private Limited (since 2025). The company operates in Healthcare.

DIN 11365581
Primary Designation Director
Industry Healthcare
First Appointment 03 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Udayhelios Hospitals Private Limited U86100AP2025PTC121930
Director03 Nov 20252025Active

Board colleagues of Lakshmi Tilak Solingapuram

Directorship timeline

Open interactive timeline →
Udayhelios Hospitals Private Limited
Premium access

Shareholding and investment profile for Lakshmi Tilak Solingapuram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmi Tilak Solingapuram

Lakshmi Tilak Solingapuram currently holds 1 directorship: Udayhelios Hospitals Private Limited (Director, since 03 Nov 2025).

Lakshmi Tilak Solingapuram was first appointed on 03 Nov 2025 as Director at Udayhelios Hospitals Private Limited.

The current boards of Lakshmi Tilak Solingapuram's companies include Haritha Pemma (Udayhelios Hospitals Private Limited), Siripi Srikanth (Udayhelios Hospitals Private Limited), Udaya Bhaskar Tupakula (Udayhelios Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available